Tsai Ben M, Finne Charles O, Nordenstam Johan F, Christoforidis Dimitrios, Madoff Robert D, Mellgren Anders
Division of Colon and Rectal Surgery, University of Minnesota, Minneapolis, Minnesota, USA.
Dis Colon Rectum. 2010 Jan;53(1):16-23. doi: 10.1007/DCR.0b013e3181bbd6ee.
Transanal endoscopic microsurgery provides a minimally invasive alternative to radical surgery for excision of benign and malignant rectal tumors. The purpose of this study was to review our experience with transanal endoscopic microsurgery to clarify its role in the treatment of different types of rectal pathology.
A prospective database documented all patients undergoing transanal endoscopic microsurgery from October 1996 through June 2008. We analyzed patient and operative factors, complications, and tumor recurrence. For recurrence analysis, we excluded patients with fewer than 6 months of follow-up, previous excisions, known metastases at initial presentation, and those who underwent immediate radical resection following transanal endoscopic microsurgery.
Two hundred sixty-nine patients underwent transanal endoscopic microsurgery for benign (n = 158) and malignant (n = 111) tumors. Procedure-related complications (21%) included urinary retention (10.8%), fecal incontinence (4.1%), fever (3.8%), suture line dehiscence (1.5%), and bleeding (1.5%). Local recurrence rates for 121 benign and 83 malignant tumors were 5% for adenomas, 9.8% for T1 adenocarcinoma, 23.5% for T2 adenocarcinoma, 100% for T3 adenocarcinoma, and 0% for carcinoid tumors. All 6 (100%) recurrent adenomas were retreated with endoscopic techniques, and 8 of 17 (47%) recurrent adenocarcinomas underwent salvage procedures with curative intent.
Transanal endoscopic microsurgery is a safe and effective method for excision of benign and malignant rectal tumors. Transanal endoscopic microsurgery can be offered for (1) curative resection of benign tumors, carcinoid tumors, and select T1 adenocarcinomas, (2) histopathologic staging in indeterminate cases, and (3) palliative resection in patients medically unfit or unwilling to undergo radical resection.
经肛门内镜显微手术为良性和恶性直肠肿瘤切除提供了一种微创替代根治性手术的方法。本研究的目的是回顾我们经肛门内镜显微手术的经验,以阐明其在治疗不同类型直肠病变中的作用。
一个前瞻性数据库记录了1996年10月至2008年6月期间所有接受经肛门内镜显微手术的患者。我们分析了患者和手术因素、并发症及肿瘤复发情况。对于复发分析,我们排除了随访时间少于6个月、既往有切除史、初次就诊时已知有转移以及经肛门内镜显微手术后立即接受根治性切除的患者。
269例患者因良性(n = 158)和恶性(n = 111)肿瘤接受了经肛门内镜显微手术。与手术相关的并发症(21%)包括尿潴留(10.8%)、大便失禁(4.1%)、发热(3.8%)、缝线裂开(1.5%)和出血(1.5%)。121例良性肿瘤和83例恶性肿瘤的局部复发率分别为:腺瘤5%,T1期腺癌9.8%,T2期腺癌23.5%,T3期腺癌100%,类癌肿瘤0%。所有6例(100%)复发性腺瘤均采用内镜技术再次治疗,17例复发性腺癌中的8例(47%)接受了有治愈意图的挽救性手术。
经肛门内镜显微手术是切除良性和恶性直肠肿瘤的一种安全有效的方法。经肛门内镜显微手术可用于:(1)良性肿瘤、类癌肿瘤及部分T1期腺癌的确切切除;(2)不确定病例的组织病理学分期;(3)身体状况不佳或不愿接受根治性切除患者的姑息性切除。